New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
06:39 EDTEWEdwards Lifesciences upgraded to Outperform from Market Perform at JMP Securities
JMP Securities upgraded Edwards Lifesciences to Outperform from Market Perform and established a $97 price target. The firm upgraded shares following positive survey results that indicate TAVI volumes will continue to grow 30%+, the approval of Sapien XT will shift market share back to Edwards and growth is coming from larger valve sizes and smaller sheaths.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
19:16 EDTEWOn The Fly: After Hours Movers
Subscribe for More Information
16:19 EDTEWEdwards Lifesciences sees Q2 EPS $1.00-$1.10, consensus $1.05
Subscribe for More Information
16:18 EDTEWEdwards Lifesciences narrows FY15 EPS view to $4.10-$4.30, consensus $4.21
Subscribe for More Information
16:17 EDTEWEdwards Lifesciences reports Q1 EPS $1.12, consensus $1.04
Subscribe for More Information
15:00 EDTEWNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use